ALB and hereditary elliptocytosis: Additionally, regarding the other scoring systems, such as the Bilirubin-Albumin-Beta-Blocker-Statin score and MASQ-HE score developed by Tapper et al [36, 37], both include adding medications, such as the use of nonselective β-blockers and statins, in addition to quality of life and physical function, to improve the performance in terms of the predictability of HE risk.